Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Bromelain vs Corticosteroids for Oral Lichen Planus
NCT06981767Phase 2Recruiting
- Sponsor
- Cairo University
- Start
- Feb 2026
- Primary completion
- Jul 2026
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of bromelain in oral lichen planus (OLP) (3 arms), sponsored by Cairo University. Primary endpoint: Clinical improvement at 4 weeks. Started Feb 2026; status: recruiting.
02
Drugs
bromelain
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT06981767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06981767.